Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2016, Article ID 5437609, 5 pages
http://dx.doi.org/10.1155/2016/5437609
Research Article

Biochemical Markers of Bone Turnover in Patients with β-Thalassemia Major: A Single Center Study from Southern Pakistan

1Department of Hematology & Blood Bank, Liaquat National Hospital and Medical College, Karachi, Pakistan
2Liaquat National Medical College, Karachi, Pakistan

Received 31 October 2015; Revised 1 February 2016; Accepted 8 February 2016

Academic Editor: Shaji Kumar

Copyright © 2016 Sadia Sultan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sultan, S. M. Irfan, R. Zeeshan, J. Kaker, and A. Kidwai, “Zinc status and its correlation with basic parameters in transfusion dependent thalassemic patients: a Pakistani perspective,” Iranian Journal of Blood and Cancer, vol. 6, no. 3, pp. 113–118, 2014. View at Google Scholar
  2. S. Sultan, S. M. Irfan, J. Kakar, and R. Zeeshan, “Effect of iron chelator desferrioxamine on serum zinc levels in patients with beta thalassemia major,” The Malaysian Journal of Pathology, vol. 37, no. 1, pp. 35–38, 2015. View at Google Scholar
  3. O. S. Salama, Y. A. Al-Tonbary, R. A. Shahin, and O. A. Sharaf Eldeen, “Unbalanced bone turnover in children with β-thalassemia,” Hematology, vol. 11, no. 3, pp. 197–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Saboor, F. Qudsia, K. Qamar, and M. Moinuddin, “Levels of calcium, corrected calcium, alkaline phosphatase and inorganic phosphorus in patients' serum with β-thalassemia major on subcutaneous deferoxamine,” Journal of Hematology & Thromboembolic Diseases, vol. 2, article 130, 2014. View at Publisher · View at Google Scholar
  5. I. Aslan, D. Canatan, N. Balta et al., “Bone mineral density in thalassemia major patients from Antalya, Turkey,” International Journal of Endocrinology, vol. 2012, Article ID 573298, 4 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Malik, S. Syed, and N. Ahmed, “Complications in transfusion-dependent patients of β-thalassemia major,” Pakistan Journal of Medical Sciences, vol. 25, no. 4, pp. 678–682, 2009. View at Google Scholar · View at Scopus
  7. A. Adil, Z. A. Sobani, A. Jabbar, S. N. Adil, and S. Awan, “Endocrine complications in patients of beta thalassemia major in a tertiary care hospital in Pakistan,” Journal of the Pakistan Medical Association, vol. 62, no. 3, pp. 307–310, 2012. View at Google Scholar · View at Scopus
  8. A. A. Hamidieh, B. Moradbeag, F. Pasha, M. Jalili, M. Hadjibabaie, and M. Keshavarznia, “High prevalence of hypoparathyroidism in patients with beta-thalassemia major,” International Journal of Hematology-Oncology and Stem Cell Research, vol. 3, no. 3, pp. 17–20, 2009. View at Google Scholar · View at Scopus
  9. A. A. Shamshirsaz, M. R. Bekheirnia, M. Kamgar et al., “Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran,” BMC Endocrine Disorders, vol. 3, article 4, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. A. Sleem, I. S. Al-Zakwani, and M. Almuslahi, “Hypoparathyroidism in adult patients with β-thalassemia major,” Sultan Qaboos University Medical Journal, vol. 7, no. 3, pp. 215–218, 2007. View at Google Scholar
  11. J. P. S. Chern and K.-H. Lin, “Hypoparathyroidism in transfusion-dependent patients with β-thalassemia,” Journal of Pediatric Hematology/Oncology, vol. 24, no. 4, pp. 291–293, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. N. G. Angelopoulos, A. Goula, G. Rombopoulos et al., “Hypoparathyroidism in transfusion-dependent patients with β-thalassemia,” Journal of Bone and Mineral Metabolism, vol. 24, no. 2, pp. 138–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Peacock, “Calcium metabolism in health and disease,” Clinical Journal of the American Society of Nephrology, vol. 5, supplement 1, pp. S23–S30, 2010. View at Publisher · View at Google Scholar
  14. N. Z. Mirhosseini, S. Shahar, M. Ghayour-Mobarhan et al., “Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents,” Journal of Bone and Mineral Metabolism, vol. 31, no. 4, pp. 468–476, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Aleem, A.-K. Al-Momen, M. S. Al-Harakati, A. Hassan, and I. Al-Fawaz, “Hypocalcemia due to hypoparathyroidism in β-thalassemia major patients,” Annals of Saudi Medicine, vol. 20, no. 5-6, pp. 364–366, 2000. View at Google Scholar · View at Scopus
  16. G. Zamboni, P. Marradi, F. Tagliaro, R. Dorizzi, and L. Tatò, “Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia major,” European Journal of Pediatrics, vol. 145, no. 1-2, pp. 133–136, 1986. View at Publisher · View at Google Scholar · View at Scopus
  17. M. G. Vogiatzi, K. A. Autio, J. E. Mait, R. Schneider, M. Lesser, and P. J. Giardina, “Low bone mineral density in adolescents with β-thalassemia,” Annals of the New York Academy of Sciences, vol. 1054, pp. 462–466, 2005. View at Publisher · View at Google Scholar
  18. P. Mahachoklertwattana, A. Chuansumrit, L. Choubtum, A. Sriphrapradang, R. Sirisriro, and R. Rajatanavin, “Bone mineral density in children and young adults with β-thalassemia trait,” Journal of Pediatric Endocrinology and Metabolism, vol. 15, no. 9, pp. 1531–1535, 2002. View at Google Scholar · View at Scopus
  19. M. Di Stefano, P. Chiabotto, C. Roggia et al., “Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs,” Journal of Bone and Mineral Metabolism, vol. 22, no. 1, pp. 53–57, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Eren and N. Yilmaz, “Biochemical markers of bone turnover and bone mineral density in patients with β-thalassaemia major,” International Journal of Clinical Practice, vol. 59, no. 1, pp. 46–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. H. Al-Elq and H. H. Al-Saeed, “Endocrinopathies in patients with thalassemias,” Saudi Medical Journal, vol. 25, no. 10, pp. 1347–1351, 2004. View at Google Scholar · View at Scopus
  22. A. T. Soliman, N. El Banna, M. A. Fattah, M. M. ElZalabani, and B. M. Ansari, “Bone mineral density in prepubertal children with β-thalassemia: correlation with growth and hormonal data,” Metabolism: Clinical and Experimental, vol. 47, no. 5, pp. 541–548, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. O. S. Salama, Y. A. Al-Tonbary, R. A. Shahin, and O. A. Eldeen, “Unbalanced bone turnover in children with β-thalassemia,” Hematology, vol. 11, no. 3, pp. 197–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. M. Chan, K. O. Ash, W. Hentschel, and J. Wu, “Effects of bilirubin on ionized calcium,” Clinical Chemistry, vol. 27, no. 1, pp. 204–205, 1981. View at Google Scholar · View at Scopus
  25. N. Napoli, E. Carmina, S. Bucchieri, C. Sferrazza, G. B. Rini, and G. Di Fede, “Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia,” Bone, vol. 38, no. 6, pp. 888–892, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Soliman, A. Adel, M. Wagdy, M. Al Ali, and N. ElMulla, “Calcium homeostasis in 40 adolescents with beta-thalassemia major: a case-control study of the effects of intramuscular injection of a megadose of cholecalciferol,” Pediatric Endocrinology Reviews, vol. 6, no. 1, pp. 149–154, 2008. View at Google Scholar · View at Scopus
  27. S. Tsitoura, N. Amarilio, P. Lapatsanis, S. Pantelakis, and S. Doxiadis, “Serum 25-hydroxyvitamin D levels in thalassaemia,” Archives of Disease in Childhood, vol. 53, no. 4, pp. 347–348, 1978. View at Publisher · View at Google Scholar · View at Scopus
  28. M. G. Vogiatzi, E. A. Macklin, F. L. Trachtenberg et al., “Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America,” British Journal of Haematology, vol. 146, no. 5, pp. 546–556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Tsitoura, N. Amarilio, P. Lapatsani, S. Pantelakis, and S. Doxiadis, “Serum 25 hydroxy vitamin D levels in thalassemia,” Archives of Disease in Childhood, vol. 53, pp. 347–348, 1978. View at Publisher · View at Google Scholar
  30. S. Malik, S. Syed, and N. Ahmed, “Complications in transfusion-dependent patients of β-thalassemia major,” Pakistan Journal of Medical Sciences, vol. 25, no. 4, pp. 678–682, 2009. View at Google Scholar
  31. F. M. Fahim, K. Saad, E. A. Askar, E. N. Eldin, and A. F. Thabet, “Growth parameters and vitamin D status in children with thalassemia major in upper Egypt,” International Journal of Hematology-Oncology and Stem Cell Research, vol. 7, no. 4, pp. 10–14, 2013. View at Google Scholar · View at Scopus
  32. A. G. Pirinççioğlu, V. Akpolat, O. Köksal, K. Haspolat, and M. Söker, “Bone mineral density in children with beta-thalassemia major in Diyarbakir,” Bone, vol. 49, no. 4, pp. 819–823, 2011. View at Publisher · View at Google Scholar · View at Scopus